期刊文献+

近交系大鼠后肢移植模型的建立及意义 被引量:1

Establishment and evaluation of hind limb allotransplantation model in rats
下载PDF
导出
摘要 目的:介绍异体复合组织移植研究中操作难度较大的大鼠后肢移植模型的建立方法,操作体会及此动物模型在复合组织移植中的意义。方法:以近交系BrownNorway(RT1n)大鼠为供体,Lewis(RT11)大鼠为受体,吻合股动、静脉为供血血管,进行近交系大鼠后肢异体移植。实验分为2组:急性排斥组(A组)术后不予免疫抑制治疗;免疫抑制组(B组)术后腹腔注射FK506剂量为1mg/kg/天。术后观察移植肢体的排斥情况及其存活时间,并取皮肤进行组织病理学检查,以此对动物模型的可靠性和实用性进行评价。结果:A组移植皮瓣均在术后(4±1)天发生明显的逐渐加重的急性免疫排斥反应;B组移植肢体均可良好存活,存活时间均>100天。皮肤组织病理学检查上,A组有血管炎、毛囊炎及真皮炎症等典型急性排斥反应表现;B组均无明显免疫排斥病理学表现。术后IL-2水平与肢体外观表现及病理学检查所见排斥反应程度相一致。结论:近交系大鼠后肢移植模型是得到广泛承认的复合组织移植模型,也是最具挑战性的动物模型之一,完善近交系大鼠后肢移植模型的建立方法,使模型不断规范化,对复合组织异体移植研究的发展具有重要意义。 Objective To demonstrate the establishment of the rat hind limb allotransplantation model which is one of the most challenging models for composite tissue allotransplantation. Methods In our study, Lewis rats were used as recipients and Brown Norway rats were used as donor. We harvest the hind limb allografts of Brown Norway rats based in the femoral artery and vein, then the allograts were orthotopicly transplanted to Lewis rats. 30 couples of rats were divided in 2 groups: Group A, acute rejection group, in which no immunosuppressor was given to the recipients after allotransplants. Group B, immunosuppression group, in which all recipients was injected with FK506 as lmg/kg/day just after allotransplants. Observe the survival days and rejection time of hind limb allografts, histopathological outcomes , and the level of IL-2 to evaluate the stability and reliability of this model. Results The rejection time was (4±1)d in Group A and (〉100)d in Group B, respectively, histopathological outcomes and the level of IL-2 were coincident with the rejection observed outside of the hind limb allografts. Conclusion Rat hind limb allotransplantation model is a stable, widely accepted and very important model for composite tissue allotransplantation.
出处 《中国美容医学》 CAS 2008年第12期1759-1763,共5页 Chinese Journal of Aesthetic Medicine
基金 国家自然科学基金资助项目(NO.30672189)
关键词 大鼠后肢移植 复合组织异体移植 动物模型 移植免疫 rat hind limb allotransplantation composite tissue allotransplantation model transplantation immunology
  • 相关文献

参考文献10

  • 1Pan H, Wang L, Zhang X, et al. Rapamycin, mycophenolate mofetil, methylprednisolone, and cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-based conditioning regimen to induce partial tolerance to hind limb allografts without cytoreductive conditioning [J]. Transplant Proc, 2008, 40(5): 1714-1721.
  • 2Ravindra KV, Wu S, Bozulic L, et al. Composite tissue transplantation: a rapidly advancing field [J]. Transplant Proc, 2008, 40(5): 1237-1248.
  • 3Pomahac B, Aflaki P, Chandraker A, et al. Facial transplantation and immunosuppressed patients: a new frontier in reconstructive surgery [J]. Transplantation, 2008,27,85 (12): 1693-1697.
  • 4Cendales LC, Kirk AD, Moresi JM,et al. Composite tissue allotransplantation: classification of clinical acute skin rejection [J]. Transplantation, 2006,15,81 (3):418-422.
  • 5Pidwell DJ, Bums C. The immunology of composite tissue transplantation[J]. Clin Plast Surg, 2007, 34(2):303-317.
  • 6Tobin GR, Breidenbach WC 3rd, Pidwell DJ, et al. Transplantation of the hand, face, and composite structures: evolution and current status [J]. Clin Plast Surg, 2007, 34(2): 271-278.
  • 7Petit F, Lantieri L, Randolph MA, Lee WP. Furore research in immunology for composite tissue allotransplantation [J]. Ann Chir Plast Esthet, 2006, 51(1):11-17.
  • 8潘华,郭树忠,王璐,张旭东,刘丹,刘垠.近交系大鼠腹部游离皮瓣移植模型的建立及意义[J].中国美容医学,2007,16(12):1672-1675. 被引量:8
  • 9Demir Y, Ozmen S, Klimczak A,et al. Tolerance induction in composite facial allograft transplantation in the rat model [J]. Plast Reconstr Surg,2004, 114(7): 1790-801.
  • 10Ulusal AE, Ulusal BG, Hung LM, et al. Establishing a composite auricle allotransplantation model in rats: introduction to transplantation of facial subunits [J]. Plast Reconstr Surg, 2005, 116 (3):811-817.

二级参考文献9

  • 1Pidwell DJ, Bums C.The immunology of composite tissue transplantation[J]. Clin Plast Stag, 2007, 34(2):303-317.
  • 2Tobin GR, Breidenbach WC 3rd, Pidwell DJ, et al. Transplantation of the hand, face, and composite structures: evolution and current status [J]. Clin Plast Surg, 2007,34(2): 271-278.
  • 3Petit F, Lantieri L, Randolph MA. Future research in immunology for composite tissue allotransplantation [J]. Ann Chit Plast Esther, 2006, 51(1):11-17.
  • 4Cendales LC, Kirk AD, Moresi JM, et al. Composite tissue allotransplantation: classification of clinical acute skin rejection [J]. Transplantation, 2005,27,80( 12): 1676-1680.
  • 5Monaco AP, Gozzo J J, Wood ME, et al. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection[J], Transplant Proc 3,1971, 1:680-683.
  • 6Romani N, Ebner S. Epidermal Langerhans cells-changing views on their function in vivo[J]. Immunol Lett, 2006,15,106(2):119-125.
  • 7Press BH, Siblcy RK, Shons AR. Limb allotransplantation in the rat: extended survival and return of nerve function with continuous cyclosporin/prednisone immunosuppression [J]. Ann Plast Surg, 1986,16(4):313-321.
  • 8Demir Y, Ozmen S, Klimczak A. Tolerance induction in composite facial allograft transplantation in the rat model [J]. Plast Reconstr Surg,2004,114(7): 1790-1801.
  • 9Ulusal AE, Ulusal BG, Hung LM. Establishing a composite auricle allotransplantation model in rats: introduction to transplantation of facial subunits[J]. Plast Reconstr Surg, 2005,116(3): 811-817.

共引文献7

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部